氨甲环酸的不同应用方式在膝关节单髁置换术中失血量的比较

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (931 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的比较关节腔注射(articular injection，AI)、静脉滴注(intravenous injection，II)联合关节腔注射(AI+II)应用氨甲环酸(tranexamic acid，TXA)以及未应用氨甲环酸对膝关节单髁置换术(unicompartmental knee arthroplasty，UKA)患者失血量(blood loss，BL)以及相关并发症的影响。方法回顾性探究山西医科大学第二医院骨科2018年9月至2020年3月行UKA治疗内侧OA的患者120例，其中男35例，女85例；年龄51~88岁，平均(69.2±7.7)岁。按随机数字表法分为三组，AI组(40例)、AI+II组(40例)以及未曾应用TXA的空白对照组(40例)。分别比较三组患者术前血红蛋白(hemoglobin，Hb)浓度、术后Hb浓度、Hb下降程度、红细胞压积(hematocrit，Hct)与部分凝血活酶时间(activated partial thromboplastin time，APTT)、凝血酶原时间(prothrombin time，PT)、D-二聚体(D-Dimer，D-Di)。结果 AI组术后Hb浓度、Hb下降程度、术后Hct分别为(124.8±4.1)g/L、(11.2±3.6)g/L、(39.1±2.4)%，AI+II组分别为(126.0±3.8)g/L、(9.3±4.4)g/L、(39.1±2.2)%，对照组分别为(120.7±4.4)g/L、(15.5±6.1)g/L、(37.8±14.2)%，AI组与AI+II组比较，差异无统计学意义(P＞0.05)；AI组、AI+II组术后Hb浓度、Hct均高于对照组，且Hb下降程度均低于对照组，差异有统计学意义(P＜0.05)。 AI组术后APTT、PT、D-Di分别为(29.7±1.2)s、(12.7±0.8)s、(473.2±74.9)ng/mL，AI+II组分别为(28.6±1.5)s、(12.2±0.5)s、(603.0±148.7)ng/mL，对照组分别为(29.8±1.4)s、(12.9±0.8)s、(486.0±80.0)ng/mL，AI组与对照组比较，差异无统计学意义(P＞0.05)；AI组和对照组术后APTT、PT都高于AI+II组，且术后D-Di均低于AI+II组，差异有统计学意义(P＜0.05)。结论在UKA术中，相比联合组应用TXA，AI组应用TXA在减少相同失血量的情况下，下肢深静脉血栓发生风险更低，且与对照组相似，更加安全。本研究认为在UKA术中单纯通过AI应用TXA，可以使患者在围术期拥有更少的失血量，且更加安全。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	黄景星 1
	2
	张民 2*
	庞俊耀 1
	2
	闫裕冰 1
	2

关键词 ：单髁置换术, 氨甲环酸, 静脉滴注, 关节腔注射, 失血量

Abstract：Objective To compare the effect of different Tranexamic acid(TXA)administration methods，namely，articular injection(AI)，intravenous injection(II) combined with AI(AI+II)，and no application of tranexamic acid on blood loss(BL)，blood transfusion(BT)，and related complications in patients undergoing unicompartmental knee arthroplasty(UKA).Methods A analysis was conducted on 120 patients，who suffered from unilateral medial compartment knee osteoarthritis and were treated with UKA from September 2018 to March 2020.There were 35 males and 85 females，aged from 51 to 88 years，with an average age of 69 years.They were divided into three groups according to the random number table method：single AI(n＝40)，AI+II(n＝40)，and control group(n＝40).The preoperative and postoperative hemoglobin(Hb) concentrations，Hb decline degree，hematocrit(Hct)test，activated partial thromboplastin time(APTT)，prothrombin time(PT)，and D-dimer were compared among the three groups.Results The postoperative Hb concentration，decrease degree of Hb and postoperative HCT in AI group were (124.8±4.1)g/L，(11.2±3.6)g/L and(39.1±2.4)% respectively，those in AI+II group were (126.0±3.8)g/L，(9.3±4.4)g/L and (39.1±2.2)% respectively，and those in control group were (120.7±4.4)g/L，(15.5±6.1)g/L and (37.8±14.2)% respectively. There was no significant difference between AI group and AI+II Group(P＞0.05).The postoperative Hb concentration and HCT of Ai Group and AI+II group were higher than those of the control group，and the decrease degree of Hb was lower than that of the control group.The difference was statistically significant (P＜0.05).APTT，PT and D-dimer in AI group were (29.7±1.2)s，(12.7±0.8)s and(473.2±74.9)ng/ml respectively，those in AI+II group were(28.6±1.5)s，(12.2±0.5)s and (603.0±148.7)ng/mL respectively，and those in control group were (29.8±1.4)s，(12.9±0.8)s and (486.0±80.0)ng/mL respectively.There was no significant difference between AI group and control group (P＞0.05)；The postoperative APTT and PT in AI group and control group were higher than those in AI+II group，and the postoperative D-dimer was lower than that in AI+II group.The difference was statistically significant (P＜0.05). Conclusion In UKA，compared with AI+II，AI can reduce the risk of lower extremity deep venous thrombosis under the condition of reducing the same blood loss，which is similar to the control group.Therefore，we believe that the application of TXA only through AI in UKA can make the patients have less blood loss and safer in the perioperative period.

Key words： unicompartmental knee arthroplasty tranexamic acid intravenous injection articular injection blood loss

通讯作者: 张民

作者简介: 黄景星(1995－ )，男，研究生在读，山西医科大学，2969258960@qq.com。

引用本文:

黄景星 1，2，张民 2*，庞俊耀 1，2，闫裕冰 1，2. 氨甲环酸的不同应用方式在膝关节单髁置换术中失血量的比较[J]. 实用骨科杂志, 2022, 28(5): 406-411.
Huang Jingxing 1，2，Zhang Min 2*，Pang Junyao 1，2，Yan Yubing 1，2. Effect of Different Tranexamic Acid Administration Methods on Lowering Blood Loss During Unicompartmental Knee Arthroplasty. sygkzz, 2022, 28(5): 406-411.

链接本文:

http://www.sygkzz.com/CN/ 或 http://www.sygkzz.com/CN/Y2022/V28/I5/406

［1］Liu XH，Fu PL，Wang SY，et al.The effect of drainage tube on bleeding and prognosis after total knee arthroplasty：a prospective cohort study［J］.J Orthop Surg Res，2014(9)：27.
［2］Arirachakaran A，Choowit P，Putananon C，et al.Is unicompartmental knee arthroplasty(UKA)superior to total knee arthroplasty(TKA)? A systematic review and meta-analysis of randomized controlled trial［J］.Eur J Orthop Surg Traumatol，2015，25(5)：799-806.
［3］Crawford DA，Berend KR，Thienpont E.Unicompartmental knee arthroplasty：US and global perspectives［J］.Orthop Clin North Am，2020，51(2)：147-159.
［4］Zakhari A，Sanders AP，Solnik MJ.Tranexamic acid in gynecologic surgery［J］.Curr Med Res Opin，2020，36(3)：513-520.
［5］Fillingham YA，Ramkumar DB，Jevsevar DS，et al.The Efficacy of tranexamic acid in total knee arthroplasty：A network meta-analysis［J］.J Arthroplasty，2018，33(10)：3090-3098.
［6］Guo P，He Z，Wang Y，et al.Efficacy and safety of oral tranexamic acid in total knee arthroplasty：A systematic review and meta-analysis［J］.Medicine，2018，97(18)：e0587.
［7］Hines JT，Petis SM，Amundson AW，et al.Intravenous tranexamic acid safely and effectively reduces transfusion rates in revision total knee arthroplasties［J］.J Bone Joint Surg(AM)，2020，102(5)：381-387.
［8］Tsukada S，Kurosaka K，Nishino M，et al.Intraoperative intravenous and intra-articular plus postoperative intravenous tranexamic acid in total knee arthroplasty：A placebocontrolled randomized controlled trial［J］.J Bone Joint Surg(AM)，2020，102(8)：687-692.
［9］Pongcharoen B，Ruetiwarangkoon C.Does tranexamic acid reduce blood loss and transfusion rates in unicompartmental knee arthroplasty? J Orthop Sci，2016，21(2)：211-215.
［10］冯硕，吴居泰，查国春，等.关节腔内注射氨甲环酸对单髁置换术围手术期失血量的影响［J］.中华骨与关节外科杂志，2016，9(5)：402-406.
［11］文涛，薛华明，马童，等.氨甲环酸对减少单髁置换术后出血量的效果评价［J］.生物骨科材料与临床研究，2016，13(5)：51-54；82.
［12］岳聚安，张启栋，郭晓忠.贫血患者膝单髁置换术氨甲环酸的应用［J］.中国矫形外科杂志，2020，28(15)：1345-1349.
［13］Chen L，Liang W，Zhang X，et al.Indications，outcomes，and complications of unicompartmental knee arthroplasty［J］.Front Biosci(Landmark Ed)，2015，20(4)：689-704.
［14］李亚坤.牛津单髁置换术前后患者下肢力线分析及术后下肢力线影响因素研究［D］.山西：山西医科大学，2021：1-38.
［15］苟旭东，彭超.膝关节置换术中局部应用与静脉注射氨甲环酸(TXA)的疗效比较［J］.西藏科技，2021(4)：67-69.
［16］Bhat A，Bhowmik DM，Vibha D，et al.Tranexamic acid overdosage-induced generalized seizure in renal failure［J］.Saudi J Kidney Dis Transpl，2014，25(1)：130-132.
［17］Fuah KW，Lim CTS，Pang DCL，et al.Seizure induced by tranexamic acid in a patient with chronic kidney disease on maintenance dialysis［J］.Saudi J Kidney Dis Transpl，2018，29(1)：207-209.
［18］Dunn AS，Petterson SC，Plancher KD.Unicondylar knee arthroplasty：intramedullary technique［J］.Clinics in sports medicine，2014，33(1)：87-104.
［19］Brown NM，Sheth NP，Davis K，et al.Total knee arthroplasty has higher postoperative morbidity than unicompartmental knee arthroplasty：a multicenter analysis［J］.J Arthroplasty，2012，27(8 Suppl)：86-90.
［20］Lin ZX，Woolf SK.Safety，efficacy，and costeffectiveness of tranexamic acid in orthopedic surgery［J］.Orthop，2016，39(2)：119-130.
［21］Polak JM，Bloom SR，Sullivan SN，et al.Enkephalin-like immunoreactivity in the human gastrointestinal tract［J］.Lancet(London，England)，1977，1(8019)：972-974.
［22］Blanié A，Bellamy L，Rhayem Y，et al.Duration of postoperative fibrinolysis after total hip or knee replacement：a laboratory follow-up study［J］.Thrombosis Res，2013，131(1)：e6-e11.
［23］DeHaven KE.Repicci Ⅱ unicompartmental knee arthroplasty［J］.Arthroscopy，2003，19(Suppl 1)：117-119.
［24］Schwab PE，Lavand'homme P，Yombi JC，et al.Lower blood loss after unicompartmental than total knee arthroplasty［J］.Knee Surg Sports Traumatol Arthrosc，2015；23(12)：3494-3500.
［25］Zhang QD，Zhang Q，Guo WS，et al.No need for use of drainage after minimally invasive unicompartmental knee arthroplasty：a prospective randomized，controlled trial［J］.Arch Orthop Trauma Surg，2015，135(5)：709-713.
［26］Aslan H，Ersan O，Baz AB，et al.Midterm results of Oxford phase 3 unicondylar knee arthroplasty for medial osteoarthritis［J］.Acta Orthop Traumatol Turc，2007，41(5)：367-372.
［27］Zhang Q，Zhang Q，Guo W，et al.The learning curve for minimally invasive Oxford phase 3 unicompartmental knee arthroplasty：cumulative summation test for learning curve(LC-CUSUM)［J］.J Orthop Surg Res，2014(9)：81.
［28］Qi YM，Wang HP，Li YJ，et al.The efficacy and safety of intravenous tranexamic acid in hip fracture surgery：A systematic review and meta-analysis［J］.J OrthopTranslation，2019(19)：1-11.
［29］Zhang S，Wang C，Shi L，et al.Multi-route applications of tranexamic acid to reduce blood loss after total knee arthroplasty：a randomized controlled trial［J］.Medicine，2019，98(30)：e16570.
［30］Maalouly J，El Assaad D，Ayoubi R，et al.Efficacy and safety of systemic tranexamic acid administration in total knee arthroplasty：A case series［J］.Int J Surg Case Rep，2020(73)：90-94.